The global market for Cancer Anorexia-Cachexia Syndrome Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cancer Anorexia-Cachexia Syndrome Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Anorexia-Cachexia Syndrome Drug.

The Cancer Anorexia-Cachexia Syndrome Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Anorexia-Cachexia Syndrome Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Anorexia-Cachexia Syndrome Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cancer Anorexia-Cachexia Syndrome Drug Market Report

Report Metric	Details
Report Name	Cancer Anorexia-Cachexia Syndrome Drug Market
CAGR	5%
Segment by Type	NEO-1940 C-1889 DLN-101 Foxo1-nRNA AVGN-7 Others
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd, RaQualia Pharma Inc, Viking Therapeutics Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cancer Anorexia-Cachexia Syndrome Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cancer Anorexia-Cachexia Syndrome Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Anorexia-Cachexia Syndrome Drug Market report?

Ans: The main players in the Cancer Anorexia-Cachexia Syndrome Drug Market are Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd, RaQualia Pharma Inc, Viking Therapeutics Inc

What are the Application segmentation covered in the Cancer Anorexia-Cachexia Syndrome Drug Market report?

Ans: The Applications covered in the Cancer Anorexia-Cachexia Syndrome Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Cancer Anorexia-Cachexia Syndrome Drug Market report?

Ans: The Types covered in the Cancer Anorexia-Cachexia Syndrome Drug Market report are NEO-1940, C-1889, DLN-101, Foxo1-nRNA, AVGN-7, Others

1 Cancer Anorexia-Cachexia Syndrome Drug Market Overview

1.1 Product Definition

1.2 Cancer Anorexia-Cachexia Syndrome Drug by Type

1.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 NEO-1940

1.2.3 C-1889

1.2.4 DLN-101

1.2.5 Foxo1-nRNA

1.2.6 AVGN-7

1.2.7 Others

1.3 Cancer Anorexia-Cachexia Syndrome Drug by Application

1.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Estimates and Forecasts

1.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue 2020-2031

1.4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales 2020-2031

1.4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Cancer Anorexia-Cachexia Syndrome Drug Market Competition by Manufacturers

2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Cancer Anorexia-Cachexia Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Product Type & Application

2.7 Global Key Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Date of Enter into This Industry

2.8 Global Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Situation and Trends

2.8.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Cancer Anorexia-Cachexia Syndrome Drug Players Market Share by Revenue

2.8.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Scenario by Region

3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2020-2031

3.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2020-2025

3.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region: 2026-2031

3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2020-2031

3.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2020-2025

3.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2026-2031

3.4 North America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country

3.4.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2031)

3.4.3 North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country

3.5.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2031)

3.5.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country

3.7.1 Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2031)

3.7.3 Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2020-2031)

4.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2020-2025)

4.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2026-2031)

4.1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2020-2031)

4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2020-2031)

4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2020-2025)

4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Type (2026-2031)

4.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2020-2031)

4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2020-2031)

5.1.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2020-2025)

5.1.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2026-2031)

5.1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2020-2031)

5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2020-2031)

5.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2020-2025)

5.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Application (2026-2031)

5.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2020-2031)

5.3 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Acacia Pharma Ltd

6.1.1 Acacia Pharma Ltd Company Information

6.1.2 Acacia Pharma Ltd Description and Business Overview

6.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.1.5 Acacia Pharma Ltd Recent Developments/Updates

6.2 Aeterna Zentaris Inc

6.2.1 Aeterna Zentaris Inc Company Information

6.2.2 Aeterna Zentaris Inc Description and Business Overview

6.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.2.5 Aeterna Zentaris Inc Recent Developments/Updates

6.3 Aphios Corp

6.3.1 Aphios Corp Company Information

6.3.2 Aphios Corp Description and Business Overview

6.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.3.5 Aphios Corp Recent Developments/Updates

6.4 Incyte Corp

6.4.1 Incyte Corp Company Information

6.4.2 Incyte Corp Description and Business Overview

6.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.4.5 Incyte Corp Recent Developments/Updates

6.5 Lakewood-Amedex Inc

6.5.1 Lakewood-Amedex Inc Company Information

6.5.2 Lakewood-Amedex Inc Description and Business Overview

6.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.5.5 Lakewood-Amedex Inc Recent Developments/Updates

6.6 Novartis AG

6.6.1 Novartis AG Company Information

6.6.2 Novartis AG Description and Business Overview

6.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.6.5 Novartis AG Recent Developments/Updates

6.7 Obexia AG

6.7.1 Obexia AG Company Information

6.7.2 Obexia AG Description and Business Overview

6.7.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.7.5 Obexia AG Recent Developments/Updates

6.8 PsiOxus Therapeutics Ltd

6.8.1 PsiOxus Therapeutics Ltd Company Information

6.8.2 PsiOxus Therapeutics Ltd Description and Business Overview

6.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.8.5 PsiOxus Therapeutics Ltd Recent Developments/Updates

6.9 RaQualia Pharma Inc

6.9.1 RaQualia Pharma Inc Company Information

6.9.2 RaQualia Pharma Inc Description and Business Overview

6.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.9.5 RaQualia Pharma Inc Recent Developments/Updates

6.10 Viking Therapeutics Inc

6.10.1 Viking Therapeutics Inc Company Information

6.10.2 Viking Therapeutics Inc Description and Business Overview

6.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio

6.10.5 Viking Therapeutics Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Chain Analysis

7.2 Cancer Anorexia-Cachexia Syndrome Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process Analysis

7.4 Cancer Anorexia-Cachexia Syndrome Drug Sales and Marketing

7.4.1 Cancer Anorexia-Cachexia Syndrome Drug Sales Channels

7.4.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors

7.5 Cancer Anorexia-Cachexia Syndrome Drug Customer Analysis

8 Cancer Anorexia-Cachexia Syndrome Drug Market Dynamics

8.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Trends

8.2 Cancer Anorexia-Cachexia Syndrome Drug Market Drivers

8.3 Cancer Anorexia-Cachexia Syndrome Drug Market Challenges

8.4 Cancer Anorexia-Cachexia Syndrome Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

PsiOxus Therapeutics Ltd

RaQualia Pharma Inc

Viking Therapeutics Inc

List of Tables

Table 1. Global Cancer Anorexia-Cachexia Syndrome Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Cancer Anorexia-Cachexia Syndrome Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Cancer Anorexia-Cachexia Syndrome Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Cancer Anorexia-Cachexia Syndrome Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Product Type & Application

Table 12. Global Key Manufacturers of Cancer Anorexia-Cachexia Syndrome Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Anorexia-Cachexia Syndrome Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2020-2025)

Table 19. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2026-2031)

Table 21. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2020-2025)

Table 53. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Type (2026-2031)

Table 54. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2020-2025)

Table 63. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Application (2026-2031)

Table 64. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. Acacia Pharma Ltd Company Information

Table 71. Acacia Pharma Ltd Description and Business Overview

Table 72. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product

Table 74. Acacia Pharma Ltd Recent Developments/Updates

Table 75. Aeterna Zentaris Inc Company Information

Table 76. Aeterna Zentaris Inc Description and Business Overview

Table 77. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product

Table 79. Aeterna Zentaris Inc Recent Developments/Updates

Table 80. Aphios Corp Company Information

Table 81. Aphios Corp Description and Business Overview

Table 82. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product

Table 84. Aphios Corp Recent Developments/Updates

Table 85. Incyte Corp Company Information

Table 86. Incyte Corp Description and Business Overview

Table 87. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product

Table 89. Incyte Corp Recent Developments/Updates

Table 90. Lakewood-Amedex Inc Company Information

Table 91. Lakewood-Amedex Inc Description and Business Overview

Table 92. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product

Table 94. Lakewood-Amedex Inc Recent Developments/Updates

Table 95. Novartis AG Company Information

Table 96. Novartis AG Description and Business Overview

Table 97. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product

Table 99. Novartis AG Recent Developments/Updates

Table 100. Obexia AG Company Information

Table 101. Obexia AG Description and Business Overview

Table 102. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product

Table 104. Obexia AG Recent Developments/Updates

Table 105. PsiOxus Therapeutics Ltd Company Information

Table 106. PsiOxus Therapeutics Ltd Description and Business Overview

Table 107. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product

Table 109. PsiOxus Therapeutics Ltd Recent Developments/Updates

Table 110. RaQualia Pharma Inc Company Information

Table 111. RaQualia Pharma Inc Description and Business Overview

Table 112. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product

Table 114. RaQualia Pharma Inc Recent Developments/Updates

Table 115. Viking Therapeutics Inc Company Information

Table 116. Viking Therapeutics Inc Description and Business Overview

Table 117. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product

Table 119. Viking Therapeutics Inc Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Cancer Anorexia-Cachexia Syndrome Drug Distributors List

Table 123. Cancer Anorexia-Cachexia Syndrome Drug Customers List

Table 124. Cancer Anorexia-Cachexia Syndrome Drug Market Trends

Table 125. Cancer Anorexia-Cachexia Syndrome Drug Market Drivers

Table 126. Cancer Anorexia-Cachexia Syndrome Drug Market Challenges

Table 127. Cancer Anorexia-Cachexia Syndrome Drug Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Cancer Anorexia-Cachexia Syndrome Drug

Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type: 2024 & 2031

Figure 4. NEO-1940 Product Picture

Figure 5. C-1889 Product Picture

Figure 6. DLN-101 Product Picture

Figure 7. Foxo1-nRNA Product Picture

Figure 8. AVGN-7 Product Picture

Figure 9. Others Product Picture

Figure 10. Global Cancer Anorexia-Cachexia Syndrome Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application: 2024 & 2031

Figure 12. Hospital

Figure 13. Clinic

Figure 14. Others

Figure 15. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (2020-2031) & (US$ Million)

Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (2020-2031) & (K Pcs)

Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Average Price (USD/Pcs) & (2020-2031)

Figure 19. Cancer Anorexia-Cachexia Syndrome Drug Report Years Considered

Figure 20. Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Manufacturers in 2024

Figure 21. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Cancer Anorexia-Cachexia Syndrome Drug Players: Market Share by Revenue in Cancer Anorexia-Cachexia Syndrome Drug in 2024

Figure 23. Cancer Anorexia-Cachexia Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2020-2031)

Figure 26. North America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2020-2031)

Figure 30. Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2020-2031)

Figure 31. Germany Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Region (2020-2031)

Figure 38. China Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2020-2031)

Figure 49. Latin America Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. UAE Cancer Anorexia-Cachexia Syndrome Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Cancer Anorexia-Cachexia Syndrome Drug by Type (2020-2031)

Figure 59. Global Revenue Market Share of Cancer Anorexia-Cachexia Syndrome Drug by Type (2020-2031)

Figure 60. Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs) by Type (2020-2031)

Figure 61. Global Sales Market Share of Cancer Anorexia-Cachexia Syndrome Drug by Application (2020-2031)

Figure 62. Global Revenue Market Share of Cancer Anorexia-Cachexia Syndrome Drug by Application (2020-2031)

Figure 63. Global Cancer Anorexia-Cachexia Syndrome Drug Price (USD/Pcs) by Application (2020-2031)

Figure 64. Cancer Anorexia-Cachexia Syndrome Drug Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32T20006

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0Q20500

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-18V16958

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cancer Anorexia-Cachexia Syndrome Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-17J7339

Global Cancer Anorexia-Cachexia Syndrome Drug Market Research Report 2025

FEATURED COMPANIES

Cancer Anorexia-Cachexia Syndrome Drug Market Size

Cancer Anorexia-Cachexia Syndrome Drug Market

Report Scope

Scope of Cancer Anorexia-Cachexia Syndrome Drug Market Report

Core Chapters

FAQ for this report

Who are the main players in the Cancer Anorexia-Cachexia Syndrome Drug Market report?

What are the Application segmentation covered in the Cancer Anorexia-Cachexia Syndrome Drug Market report?

What are the Type segmentation covered in the Cancer Anorexia-Cachexia Syndrome Drug Market report?

FEATURED COMPANIES

RELATED REPORTS